Healthcare Realty Trust Earnings Call Transcripts
Fiscal Year 2026
-
Record leasing and NOI growth in Q1 2026 drove raised FFO and NOI guidance, with robust capital allocation and redevelopment progress. Occupancy and leasing spreads improved, and the company is tracking ahead of its three-year plan, supported by strong sector fundamentals.
Fiscal Year 2025
-
2025 saw transformational progress with improved asset management, strong leasing, and $1.2B in asset sales, reducing leverage and exceeding FFO guidance. 2026 guidance projects stable FFO, continued NOI growth, and disciplined capital allocation, with redevelopment and selective JVs prioritized.
-
Strong Q3 results featured 5% FFO per share growth, robust leasing, and accelerated asset sales, driving leverage below 6x and prompting raised guidance. Portfolio repositioning and redevelopment are fueling NOI growth, while market fundamentals and buyer demand remain favorable.
-
Q2 delivered strong FFO and NOI growth, driven by higher occupancy, cost savings, and robust leasing. The strategic plan focuses on operational excellence, portfolio optimization, and capital reinvestment, with a $1B disposition target and a 23% dividend cut to fund growth.
-
Q1 results met expectations with normalized FFO per share at $0.39 and stable NOI growth. Strategic priorities include leasing, portfolio optimization, and deleveraging, with a focus on efficiency and margin improvement. Dividend maintained, with future policy tied to strategic plan execution.
Fiscal Year 2024
-
Normalized FFO per share grew 2.5% year-over-year, with record leasing and strong tenant retention. 2025 priorities include operational growth, portfolio refinement, and significant debt reduction, with dividend coverage targeted by late 2025 or early 2026.
-
Q3 2024 delivered strong leasing, NOI growth, and a return to year-over-year FFO per share growth. Asset sales and share repurchases enhanced capital flexibility, while Steward bankruptcy impacts are being actively managed with most NOI exposure secured or in process.
-
Q2 2024 saw strong operational and financial performance, with FFO per share at the high end of guidance, robust leasing, and occupancy gains. Capital allocation remains focused on JVs, asset sales, and debt repayment, with leverage expected to decline and full dividend coverage anticipated in 2025.